atherosclerotic plaque

[키워드] acute COVID-19 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 atherosclerotic atherosclerotic plaque calculated cardiac disease Cardiology caused classic Control coronary sinus coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients CSF disease Dyspnoea Endothelial dysfunction explain fatigue syndrome gadolinium healthy control healthy controls hypertrophic cardiomyopathy in some Infarction infect Infection mechanism Myocardial Myocardial inflammation no difference no significant differences overcome Patient patients pharmacological pilot study post-COVID-19 patient Post-COVID-19 patients Post-viral fatigue post-viral fatigue syndrome protocol reduced reduction in regadenoson respiratory Respiratory disease SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus significant difference significantly Stress Symptom triggered Vascular endothelium vascular inflammation velocity ventricular
[DOI] 10.1038/s41598-021-95277-z PMC 바로가기 [Article Type] Clinical Trial